Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 30, 2016, Pages 8490-8495

  Zhang, Baihao ^a,b   Chikuma, Shunsuke ^a   Hori, Shohei ^c   Fagarasan, Sidonia ^b   Honjo, Tasuku ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Institute of Physical and Chemical Research   (Japan)

Author keywords

Autoimmunity; Immune tolerance; PD 1; Regulatory t cell; T lymphocytes

Indexed keywords

PROGRAMMED DEATH 1 RECEPTOR; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; PDCD1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE PANCREATITIS; AUTOIMMUNITY; CONTROLLED STUDY; EFFECTOR CELL; ENVIRONMENTAL FACTOR; EXPERIMENTAL MODEL; FEMALE; HOMEOSTASIS; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE PROLIFERATION; MALE; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; ANIMAL; AUTOIMMUNE DISEASE; C57BL MOUSE; DISEASE MODEL; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PANCREATITIS; TRANSGENIC MOUSE;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; HUMANS; IMMUNE TOLERANCE; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PANCREATITIS; PROGRAMMED CELL DEATH 1 RECEPTOR; T-LYMPHOCYTES, REGULATORY;

EID: 84979587882     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1608873113     Document Type: Article

References (39)

1. Wu Y, et al. (2006) FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126(2):375-387.
2. Ono M, et al. (2007) Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 446(7136):685-689.
3. Wing K, et al. (2008) CTLA-4 control over Foxp3+ regulatory T cell function. Science 322(5899):271-275.
4. Rudd CE, Taylor A, Schneider H (2009) CD28 and CTLA-4 coreceptor expression and signal transduction. Immunol Rev 229(1):12-26.
5. Gough SC, Walker LS, Sansom DM (2005) CTLA4 gene polymorphism and autoimmunity. Immunol Rev 204:102-115.
6. Oda JM, Hirata BK, Guembarovski RL, Watanabe MA (2013) Genetic polymorphism in FOXP3 gene: Imbalance in regulatory T-cell role and development of human diseases. J Genet 92(1):163-171.
7. Chikuma S, Bluestone JA (2007) Expression of CTLA-4 and FOXP3 in cis protects from lethal lymphoproliferative disease. Eur J Immunol 37(5):1285-1289.
8. Vivier E, Daëron M (1997) Immunoreceptor tyrosine-based inhibition motifs. Immunol Today 18(6):286-291.
9. Parry RV, et al. (2005) CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol 25(21):9543-9553.
10. Okazaki T, Maeda A, Nishimura H, Kurosaki T, Honjo T (2001) PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domaincontaining tyrosine phosphatase 2 to phosphotyrosine. Proc Natl Acad Sci USA 98(24): 13866-13871.
11. Iwai Y, Terawaki S, Honjo T (2005) PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells. Int Immunol 17(2):133-144.
12. Okazaki T, Chikuma S, Iwai Y, Fagarasan S, Honjo T (2013) A rheostat for immune responses: The unique properties of PD-1 and their advantages for clinical application. Nat Immunol 14(12):1212-1218.
13. Fife BT, et al. (2006) Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. J Exp Med 203(12):2737-2747.
14. Okazaki T, Wang J (2005) PD-1/PD-L pathway and autoimmunity. Autoimmunity 38(5):353-357.
15. Chung Y, et al. (2011) Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat Med 17(8):983-988.
16. Franceschini D, et al. (2009) PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. J Clin Invest 119(3):551-564.
17. Jie HB, et al. (2013) Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients. Br J Cancer 109(10):2629-2635.
18. Chikuma S, et al. (2009) PD-1-mediated suppression of IL-2 production induces CD8+ T cell anergy in vivo. J Immunol 182(11):6682-6689.
19. DuPage M, Bluestone JA (2016) Harnessing the plasticity of CD4 T cells to treat immune-mediated disease. Nat Rev Immunol 16(3):149-163.
20. Zhou X, et al. (2009) Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol 10(9):1000-1007.
21. Miyao T, et al. (2012) Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity 36(2):262-275.
22. Nishimura H, Nose M, Hiai H, Minato N, Honjo T (1999) Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11(2):141-151.
23. Bettini ML, et al. (2012) Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency. Immunity 36(5):717-730.
24. Darce J, et al. (2012) An N- Terminal mutation of the Foxp3 transcription factor alleviates arthritis but exacerbates diabetes. Immunity 36(5):731-741.
25. Luche H, Weber O, Nageswara Rao T, Blum C, Fehling HJ (2007) Faithful activation of an extra-bright red fluorescent protein in "knock-in" Cre-reporter mice ideally suited for lineage tracing studies. Eur J Immunol 37(1):43-53.
26. Sage PT, Francisco LM, Carman CV, Sharpe AH (2013) The receptor PD-1 controls follicular regulatory T cells in the lymph nodes and blood. Nat Immunol 14(2): 152-161.
27. Killebrew JR, et al. (2011) A self-reactive TCR drives the development of Foxp3+ regulatory T cells that prevent autoimmune disease. J Immunol 187(2):861-869.
28. Levine AG, Arvey A, Jin W, Rudensky AY (2014) Continuous requirement for the TCR in regulatory T cell function. Nat Immunol 15(11):1070-1078.
29. Komatsu N, et al. (2014) Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis. Nat Med 20(1):62-68.
30. Bailey-Bucktrout SL, et al. (2013) Self- Antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response. Immunity 39(5): 949-962.
31. Bailey Bucktrout SL, Bluestone JA (2011) Regulatory T cells: Stability revisited. Trends Immunol 32(7):301-306.
32. Rubtsov YP, et al. (2010) Stability of the regulatory T cell lineage in vivo. Science 329(5999):1667-1671.
33. Ono M, Tanaka RJ (2016) Controversies concerning thymus-derived regulatory T cells: Fundamental issues and a new perspective. Immunol Cell Biol 94(1):3-10.
34. Kido M, et al. (2008) Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling. Gastroenterology 135(4):1333-1343.
35. Wang J, et al. (2010) PD-1 deficiency results in the development of fatal myocarditis in MRL mice. Int Immunol 22(6):443-452.
36. Parietti V, Monneaux F, Décossas M, Muller S (2008) Function of CD4+, CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells. Arthritis Rheum 58(6):1751-1761.
37. Bertsias GK, et al. (2009) Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus. Arthritis Rheum 60(1):207-218.
38. Nishimura H, Minato N, Nakano T, Honjo T (1998) Immunological studies on PD-1 deficient mice: Implication of PD-1 as a negative regulator for B cell responses. Int Immunol 10(10):1563-1572.
39. Molinero LL, Miller ML, Evaristo C, Alegre ML (2011) High TCR stimuli prevent induced regulatory T cell differentiation in a NF-κB-dependent manner. J Immunol 186(8): 4609-4617.